AMDL Inc.: The Tustin development-stage biomedical company...

AMDL Inc.: The Tustin development-stage biomedical company said Monday that it has closed a private placement of one-year convertible notes and completed the initial phase of an equity private placement of common stock and warrants. It has received $125,000 and expects that proceeds from these and subsequent placements will raise a total of $400,000 to $625,000.